Sign Up to like & get
recommendations!
0
Published in 2020 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v8.i22.5670
Abstract: BACKGROUND Biliary cystadenoma (BCA) is a rare benign tumor, accounting for only 5% of reported cystic lesions of the liver. Given its potential for malignancy and high rate of recurrence, surgical resection is the preferred…
read more here.
Keywords:
bca;
diagnosis;
biliary cystadenoma;
case ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.676092
Abstract: Apatinib is a new oral tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor-2. It has been proven effective in treating multiple solid tumors. Herein, we report the case of a 67-year-old Chinese patient…
read more here.
Keywords:
apatinib;
biliary cystadenoma;
treatment;
malignant transformation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1003885
Abstract: Background Intrahepatic biliary cystadenoma (IBC) is a rare benign cystic tumor of the liver. So far, it has not been comprehensively understood, which causes incorrect diagnosis, treatment confusion, and even inappropriate treatment. Here, we reviewed…
read more here.
Keywords:
ibc;
cyst;
lessons learned;
intrahepatic biliary ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1165979
Abstract: Biliary cystadenoma (also called mucinous cystic neoplasm with low-grade intraepithelial neoplasia) is a rare cystic tumor that arises from the biliary epithelium. The cause of biliary cystadenoma is still unclear. Jaundice is a rare presentation…
read more here.
Keywords:
cystadenoma;
biliary cystadenoma;
jaundice;
bile duct ... See more keywords